| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.2 | 6e-05 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.18 | 0.0001 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.19 | 0.0001 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.16 | 0.0007 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.15 | 0.003 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.14 | 0.003 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.14 | 0.004 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.14 | 0.006 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.14 | 0.01 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.095 | 0.07 |